Extracorporeal magnetic approach to reduce the unwanted side-effects and improve antibacterial activity of Ag/Fe<sub>3</sub> O<sub>4</sub> nanocomposites in rat.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 29076251.
- Also identified by DOI 10.1002/jbm.b.33998.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
While Ag nanoparticles hold great promise for broad spectrum antibacterial activity, the potential risks of Ag nanoparticles (NPs) on human health remain a challenge. In this study, Ag/Fe<sub>3</sub> O<sub>4</sub> composites have been successfully prepared and characterized by transmission electron microscopy, X-ray powder diffraction, and Fourier-transform infrared spectroscopy, and their magnetic and antibacterial properties have been assessed. In vivo results show that the antibacterial effect of 500 μg/mL Ag/Fe<sub>3</sub> O<sub>4</sub> nanocomposites was significantly higher than that of 1000 μg/mL AgNPs after 72 h of treatment (p < 0.01). Hematoxylin and eosin (HE) staining showed that squamous epithelium and dermis collagen fibers formed in the Ag/Fe<sub>3</sub> O<sub>4</sub> group after 8 days treatment. Wound closure was significantly better for the Ag/Fe<sub>3</sub> O<sub>4</sub> group than for the AgNPs group. On the other hand, there was less Ag in blood, liver, and kidney in the Ag/Fe<sub>3</sub> O<sub>4</sub> group, as more Ag was retained in the wound. According to lactate dehydrogenase, γ-glutamyl transpeptidase, and reactive oxygen species results, Ag/Fe<sub>3</sub> O<sub>4</sub> nanocomposites caused less unwanted side-effects. This work presents a new paradigm to reduce the unwanted side-effects of AgNPs and improve their antibacterial activity, providing a new avenue for wound healing. © 2017 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 106B: 2029-2036, 2018.
Medical subject headings
- Anti-Bacterial Agents
- Ferrosoferric Oxide
- Nanocomposites
- Reactive Oxygen Species
- Silver
- Wound Infection